Table 3. Adverse Events.*.
Event | REGEN-COV (N=1311) |
Placebo (N=1306) |
---|---|---|
number of participants (percent) | ||
Symptomatic Covid-19 | 15 (1.1) | 112 (8.6) |
Asymptomatic Covid-19 | 54 (4.1) | 108 (8.3) |
Headache | 24 (1.8) | 46 (3.5) |
Injection-site reaction | 55 (4.2) | 19 (1.5) |
Shown are the adverse events that occurred in at least 2% of the participants, regardless of the participants’ SARS-CoV-2 serologic status at baseline.